Treatment | Children with Cancer UK

Filter by Cancer Type

An exploratory pilot study to enable development of improved drug therapy for childhood bone cancer

A pilot Investigation of the ZFP36L1 protein as a candidate therapeutic target in osteosarcoma cells

Dr John Murphy, University of Westminster

Improving the treatment of children with relapsed or persistent acute lymphoblastic leukaemia

Optimising the use of repurposed drugs to improve the treatment of children with ALL

Prof. Julie Irving, Newcastle University

Investigating the long-term health impacts of surviving childhood cancer

Investigating late effects of surviving childhood cancer

Dr Defne Saatci, University of Oxford

Developing targeted CAR T-cell therapy for hard-to-treat Acute Myeloid Leukaemia

Identification of novel surface antigen targets for CAR T-cell strategies in paediatric Acute Myeloid Leukaemia stem cells

Dr Macarena Oporto Espuelas, UCL Great Ormond Street Institute of Child Health

Developing 3-dimensional multicellular models of osteosarcoma

Developing 3-dimensional multicellular models of osteosarcoma

Dr Claire Clarkin (wearing red coat), University of Southampton

How do genes drive the growth and spread of osteosarcoma?

Developmental states of localised and metastatic osteosarcoma cells – a knowledge bank for novel biomarkers and therapeutic approaches

Dr Sam Behjati, Wellcome Sanger Institute

1 2 3 4 5 6 … 19